Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb® immunoadsorption-Reference-Cited by-同舟云学术

Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb® immunoadsorption

Published:2003-11 Issue:10 Volume:32 Page:1015-1019
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Rabitsch W,Knöbl P,Prinz E,Keil F,Greinix H,Kalhs P,Worel N,Jansen M,Hörl W H,Derfler K

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1704264.pdf

Reference15 articles.

1. Stussi G, Muntwyler J, Passweg JR et al. Consequences of ABO incompatibility in allogeneic stem cell transplantation. Bone Marrow Transplant 2002; 30: 87–93.

2. Bolan CD, Leitman SF, Griffith LM et al. Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood 2001; 98: 1687–1694.

3. Zaucha JM, Mielcarek M, Takatu A et al. Engraftment of early erythroid progenitors is not delayed after non-myelo-ablative major ABO-incompatible haematopoietic stem cell transplantation. Br J Haematol 2002; 119: 740–750.

4. Sniecinski IJ, Oien L, Petz LD, Blume KG . Immunohematologic consequences of major ABO-mismatched bone marrow transplantation. Transplantation 1988; 45: 530–533.

5. Lee JH, Lee JH, Choi SJ et al. Changes of isoagglutinin titres after ABO-incompatible allogeneic stem cell transplantation. Br J Haematol 2003; 120: 702–710.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immuno-hematological monitoring after allogeneic stem cell transplantation: a single-center, prospective study of 104 patients;BLOOD TRANSFUS-ITALY;2022

2. Treatment for pure red cell aplasia after major ABO‐incompatible allogeneic stem cell transplantation: a multicentre study;British Journal of Haematology;2021-04-12

3. Antigen-Specific Immunoadsorption With the Glycosorb® ABO Immunoadsorption System as a Novel Treatment Modality in Pure Red Cell Aplasia Following Major and Bidirectional ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation;Frontiers in Medicine;2020-10-22

4. Impact of ABO blood group incompatibility on the outcomes of allogeneic hematopoietic stem cell transplantation;Transfusion and Apheresis Science;2020-02

5. Impact of ABO incompatibility on outcomes after haploidentical hematopoietic stem cell transplantation for severe aplastic anemia;Bone Marrow Transplantation;2020-01-13